Perspectives on Targeting RNA with Small Molecules to Capture Opportunities at the Intersection of Chemistry, Biology, and Medicine – JACS
Press Release Expansion Therapeutics Names Elliot Ehrich, M.D., Chief Medical Officer Former EVP of R&D and Chief Medical Officer at Alkermes joins Expansion to advance portfolio…Expansion TherapeuticsNovember 13, 2018
Matthew D. Disney, Ph.D., Scientific Founder of ExpansionRx, Named BioFlorida’s Entrepreneur of the Year
Event Matthew Disney, Ph.D., Presents at the 2018 Myotonic Dystrophy Foundation Annual Conference Expansion TherapeuticsOctober 4, 2018
Novel RNA-Modifying Tool Corrects Genetic Diseases, Including Driver of Triple-negative Breast Cancer – TSRI
